Page last updated: 2024-08-26

wr 1065 and Neuroblastoma

wr 1065 has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berthold, F; Fulda, S; Oster, W	1
Berthold, F; Fichtner, I; Fulda, S; Hero, B	1

Trials

1 trial(s) available for wr 1065 and Neuroblastoma

Article	Year
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients. Medical and pediatric oncology, 2001, Volume: 36, Issue:1 Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays	2001

Article

Year

Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.

Medical and pediatric oncology, 2001, Volume: 36, Issue:1

Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays

2001

Other Studies

1 other study(ies) available for wr 1065 and Neuroblastoma

Article	Year
Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitro. Anti-cancer drugs, 1997, Volume: 8, Issue:1 Topics: Amifostine; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Cell Division; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Humans; Mercaptoethylamines; Neuroblastoma; Radiation-Protective Agents; Tumor Cells, Cultured	1997

Article

Year

Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitro.

Anti-cancer drugs, 1997, Volume: 8, Issue:1

Topics: Amifostine; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Cell Division; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Humans; Mercaptoethylamines; Neuroblastoma; Radiation-Protective Agents; Tumor Cells, Cultured

1997